Phadke, M., Remsing Rix, L. L., Smalley, I., Bryant, A. T., Luo, Y., Lawrence, H. R., . . . Smalley, K. S. M. (2017). Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition. Mol Oncol.
Style de citation ChicagoPhadke, Manali, et al. "Dabrafenib Inhibits the Growth of BRAF‐WT Cancers Through CDK16 and NEK9 Inhibition." Mol Oncol 2017.
Style de citation MLAPhadke, Manali, et al. "Dabrafenib Inhibits the Growth of BRAF‐WT Cancers Through CDK16 and NEK9 Inhibition." Mol Oncol 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.